EGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating Mutations
1 clinical trials · Condition
◉ Watch EGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating Mutations
| Record | Firm | Date |
|---|---|---|
| A Study of ASP8273 in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Naïve Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations (NCT02500927) | Astellas Pharma Inc | 2015-06-25 |
Track EGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating Mutations automatically
Every clearance here is in the API, with alerts when new ones post.